XML 81 R71.htm IDEA: XBRL DOCUMENT v3.23.2
Revenue Recognition - Disaggregation of Revenue (Details)
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 100.00% 100.00% 100.00% 100.00%
Pharma and Biotech        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 40.00% 15.00% 35.00% 16.00%
Agriculture        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 20.00% 4.00% 23.00% 4.00%
Customer And Technology        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 14.00% 61.00% 12.00% 52.00%
Food And Nutrition        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 11.00% 9.00% 13.00% 9.00%
Industrial And Environment        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 11.00% 8.00% 12.00% 16.00%
Government and Defense [Member]        
Disaggregation of Revenue [Line Items]        
Total Cell Engineering revenue 4.00% 3.00% 5.00% 3.00%